MedX Health Corp (TSXV:MDX)
0.0500
0.00 (0.00%)
Aug 21, 2026, 12:11 PM EST
MedX Health Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5.92 | -6.29 | -3.65 | -4.58 | -5.13 | -5.32 |
Depreciation & Amortization | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Loss (Gain) From Sale of Assets | - | - | - | -0.6 | - | - |
Stock-Based Compensation | 0.27 | 0.87 | 0.14 | 0.31 | 0.33 | 0.23 |
Provision & Write-off of Bad Debts | - | - | - | 0.06 | 0.14 | 0.06 |
Other Operating Activities | 1.18 | 1.27 | 0.77 | 1.52 | 0.93 | 0.49 |
Change in Accounts Receivable | -0.06 | 0.01 | -0.02 | -0.06 | -0.13 | -0.03 |
Change in Inventory | 0.25 | 0.19 | -0.04 | 0.16 | -0.01 | 0 |
Change in Accounts Payable | -0.1 | 0.07 | 0.41 | -0.21 | 0.93 | 0.01 |
Change in Unearned Revenue | -0 | -0 | 0 | -0 | -0 | -0.01 |
Change in Other Net Operating Assets | 0.27 | 0.1 | -0.16 | -0.07 | 0.1 | 0 |
Operating Cash Flow | -4.05 | -3.73 | -2.51 | -3.42 | -2.8 | -4.52 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | -0 | - | - | - | -0.02 |
Investing Cash Flow | -0 | -0 | - | - | - | -0.02 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 1.82 | 2.21 | 1.14 | 1.4 | 0.15 |
Long-Term Debt Issued | - | - | - | 1.91 | 1.51 | 3.64 |
Total Debt Issued | 2.36 | 1.82 | 2.21 | 3.05 | 2.91 | 3.79 |
Short-Term Debt Repaid | - | -0 | -0.05 | -0.05 | -0.05 | -0.09 |
Long-Term Debt Repaid | - | -0.05 | -0.05 | -0.04 | -0.04 | -0.03 |
Total Debt Repaid | -0.12 | -0.06 | -0.1 | -0.09 | -0.09 | -0.12 |
Net Debt Issued (Repaid) | 2.24 | 1.76 | 2.1 | 2.95 | 2.82 | 3.67 |
Issuance of Common Stock | 1.83 | 1.83 | 0.43 | 0.46 | 0.02 | 0.71 |
Other Financing Activities | - | - | - | - | - | 0.22 |
Financing Cash Flow | 4.07 | 3.59 | 2.53 | 3.42 | 2.84 | 4.6 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.02 | -0.14 | 0.02 | -0 | 0.04 | 0.07 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.05 | -3.73 | -2.51 | -3.42 | -2.8 | -4.53 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -749.90% | -788.56% | -512.70% | -750.32% | -548.53% | -805.04% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 |
Levered Free Cash Flow | -2.86 | -2.49 | -1.91 | -3.72 | -1.81 | -3.11 |
Unlevered Free Cash Flow | -1.82 | -1.4 | -1.07 | -2.37 | -1.02 | -2.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.73 | 0.73 | 0.58 | 0.6 | 0.34 | 0.23 |
Change in Working Capital | 0.36 | 0.37 | 0.19 | -0.19 | 0.88 | -0.03 |